{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:39:19Z","timestamp":1791272359731,"version":"4.1.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"18","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Astrocytoma (glioma) formation in neurofibromatosis type 1 (NF1) occurs preferentially along the optic pathway during the first decade of life. The molecular basis for this unique pattern of gliomagenesis is unknown. Previous studies in mouse Nf1 optic glioma models suggest that this patterning results from cooperative effects of Nf1 loss in glial cells and the action of factors derived from the surrounding Nf1+\/\u2212 brain. Because CXCL12 is a stroma-derived growth factor for malignant brain tumors, we tested the hypothesis that CXCL12 functions in concert with Nf1 loss to facilitate NF1-associated glioma growth. Whereas CXCL12 promoted cell death in wild-type astrocytes, it increased Nf1\u2212\/\u2212 astrocyte survival. This increase in Nf1\u2212\/\u2212 astrocyte survival in response to CXCL12 was due to sustained suppression of intracellular cyclic AMP (cAMP) levels. Moreover, the ability of CXCL12 to suppress cAMP and increase Nf1\u2212\/\u2212 astrocyte survival was a consequence of mitogen-activated protein\/extracellular signal-regulated kinase kinase\u2013dependent inhibition of CXCL12 receptor (CXCR4) desensitization. In support of an instructive role for CXCL12 in facilitating optic glioma growth, we also show that CXCL12 expression along the optic pathway is higher in infant children and young mice and is associated with low levels of cAMP. CXCL12 expression declines in multiple brain regions with increasing age, correlating with the age-dependent decline in glioma growth in children with NF1. Collectively, these studies provide a mechanism for the unique pattern of NF1-associated glioma growth. [Cancer Res 2007;67(18):8588\u201395]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-2220","type":"journal-article","created":{"date-parts":[[2007,9,17]],"date-time":"2007-09-17T13:53:12Z","timestamp":1190037192000},"page":"8588-8595","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Spatiotemporal Differences in CXCL12 Expression and Cyclic AMP Underlie the Unique Pattern of Optic Glioma Growth in Neurofibromatosis Type 1"],"prefix":"10.1158","volume":"67","author":[{"given":"Nicole M.","family":"Warrington","sequence":"first","affiliation":[{"name":"1Pediatrics, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Mark","family":"Woerner","sequence":"additional","affiliation":[{"name":"1Pediatrics, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish C.","family":"Daginakatte","sequence":"additional","affiliation":[{"name":"2Neurology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplab","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"2Neurology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Perry","sequence":"additional","affiliation":[{"name":"3Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Gutmann","sequence":"additional","affiliation":[{"name":"2Neurology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Rubin","sequence":"additional","affiliation":[{"name":"1Pediatrics, Departments of"},{"name":"2Neurology,"},{"name":"4Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,9,17]]},"reference":[{"key":"2022061623190000300_B1","unstructured":"Friedman J, Gutmann D, MacCollin M, Riccardi V. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. 3rd ed. Johns Hopkins Press; 1999."},{"key":"2022061623190000300_B2","doi-asserted-by":"crossref","unstructured":"Rubin JB, Gutmann DH. Neurofibromatosis type I\u2014a model for nervous system tumour formation? Nat Cancer Rev\u20082005; 5: 557\u201364.","DOI":"10.1038\/nrc1653"},{"key":"2022061623190000300_B3","doi-asserted-by":"crossref","unstructured":"Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol\u20081997; 41: 143\u20139.","DOI":"10.1002\/ana.410410204"},{"key":"2022061623190000300_B4","doi-asserted-by":"crossref","unstructured":"Gutmann DH, Donahoe J, Brown T, James CD, Perry A. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol\u20082000; 26: 361\u20137.","DOI":"10.1046\/j.1365-2990.2000.00258.x"},{"key":"2022061623190000300_B5","doi-asserted-by":"crossref","unstructured":"Gutmann DH, James CD, Poyhonen M, et al. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1. Neurology\u20082003; 61: 1397\u2013400.","DOI":"10.1212\/WNL.61.10.1397"},{"key":"2022061623190000300_B6","doi-asserted-by":"crossref","unstructured":"Kluwe L, Hagel C, Tatagiba M, et al. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J Neuropathol Exp Neurol\u20082001; 60: 917\u201320.","DOI":"10.1093\/jnen\/60.9.917"},{"key":"2022061623190000300_B7","unstructured":"Bajenaru ML, Hernandez MR, Perry A, et al. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res\u20082003; 63: 8573\u20137."},{"key":"2022061623190000300_B8","doi-asserted-by":"crossref","unstructured":"Dasgupta B, Li W, Perry A, Gutmann DH. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. Cancer Res\u20082005; 65: 236\u201345.","DOI":"10.1158\/0008-5472.236.65.1"},{"key":"2022061623190000300_B9","doi-asserted-by":"crossref","unstructured":"Bajenaru ML, Zhu Y, Hedrick NM, Donahoe J, Parada LF, Gutmann DH. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol\u20082002; 22: 5100\u201313.","DOI":"10.1128\/MCB.22.14.5100-5113.2002"},{"key":"2022061623190000300_B10","doi-asserted-by":"crossref","unstructured":"Bajenaru ML, Garbow JR, Perry A, Hernandez MR, Gutmann DH. Natural history of neurofibromatosis 1\u2013associated optic nerve glioma in mice. Ann Neurol\u20082005; 57: 119\u201327.","DOI":"10.1002\/ana.20337"},{"key":"2022061623190000300_B11","doi-asserted-by":"crossref","unstructured":"Ballester R, Marchuk D, Boguski M, et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell\u20081990; 63: 851\u20139.","DOI":"10.1016\/0092-8674(90)90151-4"},{"key":"2022061623190000300_B12","doi-asserted-by":"crossref","unstructured":"Martin GA, Viskochil D, Bollag G, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell\u20081990; 63: 843\u20139.","DOI":"10.1016\/0092-8674(90)90150-D"},{"key":"2022061623190000300_B13","doi-asserted-by":"crossref","unstructured":"Xu GF, O'Connell P, Viskochil D, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell\u20081990; 62: 599\u2013608.","DOI":"10.1016\/0092-8674(90)90024-9"},{"key":"2022061623190000300_B14","doi-asserted-by":"crossref","unstructured":"Marchuk DA, Saulino AM, Tavakkol R, et al. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics\u20081991; 11: 931\u201340.","DOI":"10.1016\/0888-7543(91)90017-9"},{"key":"2022061623190000300_B15","doi-asserted-by":"crossref","unstructured":"Gutmann DH, Wood DL, Collins FS. Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci U S A\u20081991; 88: 9658\u201362.","DOI":"10.1073\/pnas.88.21.9658"},{"key":"2022061623190000300_B16","doi-asserted-by":"crossref","unstructured":"Andersen LB, Ballester R, Marchuk DA, et al. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol\u20081993; 13: 487\u201395.","DOI":"10.1128\/mcb.13.1.487-495.1993"},{"key":"2022061623190000300_B17","doi-asserted-by":"crossref","unstructured":"Phillips RA, Hunter JL, Eccleston JF, Webb MR. The mechanism of Ras GTPase activation by neurofibromin. Biochemistry\u20082003; 42: 3956\u201365.","DOI":"10.1021\/bi027316z"},{"key":"2022061623190000300_B18","doi-asserted-by":"crossref","unstructured":"DeClue JE, Papageorge AG, Fletcher JA, et al. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell\u20081992; 69: 265\u201373.","DOI":"10.1016\/0092-8674(92)90407-4"},{"key":"2022061623190000300_B19","doi-asserted-by":"crossref","unstructured":"Burchill SA, Berry PA, Bradbury FM, Lewis IJ. Contrasting levels of p21ras activation and expression of neurofibromin in peripheral primitive neuroectodermal tumour and neuroblastoma cells, and their response to retinoic acid. J Neurol Sci\u20081998; 157: 129\u201337.","DOI":"10.1016\/S0022-510X(98)00083-5"},{"key":"2022061623190000300_B20","doi-asserted-by":"crossref","unstructured":"Bollag G, Clapp DW, Shih S, et al. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet\u20081996; 12: 144\u20138.","DOI":"10.1038\/ng0296-144"},{"key":"2022061623190000300_B21","doi-asserted-by":"crossref","unstructured":"Guha A. Ras activation in astrocytomas and neurofibromas. Can J Neurol Sci\u20081998; 25: 267\u201381.","DOI":"10.1017\/S0317167100034272"},{"key":"2022061623190000300_B22","doi-asserted-by":"crossref","unstructured":"Feldkamp MM, Angelov L, Guha A. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway. Surg Neurol\u20081999; 51: 211\u20138.","DOI":"10.1016\/S0090-3019(97)00356-X"},{"key":"2022061623190000300_B23","doi-asserted-by":"crossref","unstructured":"Klein RS, Rubin JB, Gibson HD, et al. SDF-1 \u03b1 induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development\u20082001; 128: 1971\u201381.","DOI":"10.1242\/dev.128.11.1971"},{"key":"2022061623190000300_B24","doi-asserted-by":"crossref","unstructured":"Rubin JB, Kung AL, Klein RS, et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A\u20082003; 100: 13513\u20138.","DOI":"10.1073\/pnas.2235846100"},{"key":"2022061623190000300_B25","doi-asserted-by":"crossref","unstructured":"Peng H, Huang Y, Rose J, et al. Stromal cell-derived factor 1\u2013mediated CXCR4 signaling in rat and human cortical neural progenitor cells. J Neurosci Res\u20082004; 76: 35\u201350.","DOI":"10.1002\/jnr.20045"},{"key":"2022061623190000300_B26","doi-asserted-by":"crossref","unstructured":"The I, Hannigan GE, Cowley GS, et al. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science\u20081997; 276: 791\u20134.","DOI":"10.1126\/science.276.5313.791"},{"key":"2022061623190000300_B27","doi-asserted-by":"crossref","unstructured":"Guo HF, The I, Hannan F, Bernards A, Zhong Y. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science\u20081997; 276: 795\u20138.","DOI":"10.1126\/science.276.5313.795"},{"key":"2022061623190000300_B28","doi-asserted-by":"crossref","unstructured":"Dasgupta B, Dugan LL, Gutmann DH. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes. J Neurosci\u20082003; 23: 8949\u201354.","DOI":"10.1523\/JNEUROSCI.23-26-08949.2003"},{"key":"2022061623190000300_B29","doi-asserted-by":"crossref","unstructured":"Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB. Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4\u2013specific antibodies. Cancer Res\u20082005; 65: 11392\u20139.","DOI":"10.1158\/0008-5472.CAN-05-0847"},{"key":"2022061623190000300_B30","doi-asserted-by":"crossref","unstructured":"Saura J, Tusell JM, Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia\u20082003; 44: 183\u20139.","DOI":"10.1002\/glia.10274"},{"key":"2022061623190000300_B31","doi-asserted-by":"crossref","unstructured":"Yang L, Jackson E, Woerner BM, Perry A, Piwnica-Worms D, Rubin JB. Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res\u20082007; 67: 651\u20138.","DOI":"10.1158\/0008-5472.CAN-06-2762"},{"key":"2022061623190000300_B32","doi-asserted-by":"crossref","unstructured":"Klein RS, Rubin JB. Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity. Trends Immunol\u20082004; 25: 306\u201314.","DOI":"10.1016\/j.it.2004.04.002"},{"key":"2022061623190000300_B33","doi-asserted-by":"crossref","unstructured":"De La Luz Sierra M, Yang F, Narazaki M, et al. Differential processing of stromal-derived factor-1\u03b1 and stromal-derived factor-1\u03b2 explains functional diversity. Blood\u20082004; 103: 2452\u20139.","DOI":"10.1182\/blood-2003-08-2857"},{"key":"2022061623190000300_B34","doi-asserted-by":"crossref","unstructured":"Luo Y, Cai J, Liu Y, et al. Microarray analysis of selected genes in neural stem and progenitor cells. J Neurochem\u20082002; 83: 1481\u201397.","DOI":"10.1046\/j.1471-4159.2002.01260.x"},{"key":"2022061623190000300_B35","doi-asserted-by":"crossref","unstructured":"Ehtesham M, Yuan X, Kabos P, et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia\u20082004; 6: 287\u201393.","DOI":"10.1593\/neo.03427"},{"key":"2022061623190000300_B36","doi-asserted-by":"crossref","unstructured":"Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol\u20082004; 72: 111\u201327.","DOI":"10.1016\/j.pneurobio.2004.02.001"},{"key":"2022061623190000300_B37","doi-asserted-by":"crossref","unstructured":"Gomez Del Pulgar T, De Ceballos ML, Guzman M, Velasco G. Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase\/protein kinase B pathway. J Biol Chem\u20082002; 277: 36527\u201333.","DOI":"10.1074\/jbc.M205797200"},{"key":"2022061623190000300_B38","doi-asserted-by":"crossref","unstructured":"Pesic M, Drabek K, Esler C, Ruzdijic S, Pejanovic V, Pietrzkowski Z. Inhibition of cell growth and proliferation in human glioma cells and normal human astrocytes induced by 8-Cl-cAMP and tiazofurin. Nucleosides Nucleotides Nucleic Acids\u20082000; 19: 963\u201375.","DOI":"10.1080\/15257770008033036"},{"key":"2022061623190000300_B39","doi-asserted-by":"crossref","unstructured":"Dugan LL, Kim JS, Zhang Y, et al. Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J Biol Chem\u20081999; 274: 25842\u20138.","DOI":"10.1074\/jbc.274.36.25842"},{"key":"2022061623190000300_B40","doi-asserted-by":"crossref","unstructured":"Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci\u20082004; 27: 107\u201344.","DOI":"10.1146\/annurev.neuro.27.070203.144206"},{"key":"2022061623190000300_B41","doi-asserted-by":"crossref","unstructured":"Ferguson SS, Barak LS, Zhang J, Caron MG. G-protein\u2013coupled receptor regulation: role of G-protein\u2013coupled receptor kinases and arrestins. Can J Physiol Pharmacol\u20081996; 74: 1095\u2013110.","DOI":"10.1139\/y96-124"},{"key":"2022061623190000300_B42","doi-asserted-by":"crossref","unstructured":"Penn RB, Pronin AN, Benovic JL. Regulation of G protein\u2013coupled receptor kinases. Trends Cardiovasc Med\u20082000; 10: 81\u20139.","DOI":"10.1016\/S1050-1738(00)00053-0"},{"key":"2022061623190000300_B43","doi-asserted-by":"crossref","unstructured":"Orsini MJ, Parent JL, Mundell SJ, Marchese A, Benovic JL. Trafficking of the HIV coreceptor CXCR4: role of arrestins and identification of residues in the C-terminal tail that mediate receptor internalization. J Biol Chem\u20081999; 274: 31076\u201386.","DOI":"10.1074\/jbc.274.43.31076"},{"key":"2022061623190000300_B44","doi-asserted-by":"crossref","unstructured":"Pitcher JA, Tesmer JJ, Freeman JL, Capel WD, Stone WC, Lefkowitz RJ. Feedback inhibition of G protein\u2013coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases. J Biol Chem\u20081999; 274: 34531\u20134.","DOI":"10.1074\/jbc.274.49.34531"},{"key":"2022061623190000300_B45","doi-asserted-by":"crossref","unstructured":"Bajenaru ML, Donahoe J, Corral T, et al. Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia\u20082001; 33: 314\u201323.","DOI":"10.1002\/1098-1136(20010315)33:4<314::AID-GLIA1030>3.0.CO;2-Q"},{"key":"2022061623190000300_B46","doi-asserted-by":"crossref","unstructured":"Zhu Y, Harada T, Liu L, et al. Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation. Development\u20082005; 132: 5577\u201388.","DOI":"10.1242\/dev.02162"},{"key":"2022061623190000300_B47","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell\u20082000; 100: 57\u201370.","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"2022061623190000300_B48","doi-asserted-by":"crossref","unstructured":"Daginakatte GC, Gutmann DH. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. Hum Mol Genet\u20082007; 16: 1098\u2013112.","DOI":"10.1093\/hmg\/ddm059"},{"key":"2022061623190000300_B49","doi-asserted-by":"crossref","unstructured":"Yang FC, Ingram DA, Chen S, et al. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+\/\u2212 mast cells. J Clin Invest\u20082003; 112: 1851\u201361.","DOI":"10.1172\/JCI19195"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/18\/8588\/2576022\/8588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/18\/8588\/2576022\/8588.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T22:13:45Z","timestamp":1655417625000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/18\/8588\/533779\/Spatiotemporal-Differences-in-CXCL12-Expression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,15]]},"references-count":49,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2007,9,17]]},"published-print":{"date-parts":[[2007,9,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-2220","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22366319","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366319.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366313.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366310.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366310","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366313","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6495086.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6495086","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,15]]}}}